Laser Thermal Therapy For Recurrent Head And Neck Cancer: The UCLA Experience | 12385
Otolaryngology: Open Access
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Although major progress has been made in surgery, radiation, and chemotherapy for the treatment of malignancy during the last 30
years, there has been little improvement in the survival of patients with recurrent or advanced head and neck cancer.Laser-induced
thermotherapy (LITT) is a non-surgical method for treating tumors in solid organs. The method is experimental and considered primarily
in treating patients with recurrent tumors when surgery is not an option.A recent phase II study at our institution showed that palliative
LITT for 106 patients with recurrent lesions presented the best results in oral cavity tumors, in which mean survival was 29.1 months, as
compared to neck tumors (mean 14.4 +/- 6.9 months; range 7.5-20.7 months; with a 95% confidence interval).Because of the ease and
accessibility for surgery and their loco-regional biological behavior, head and neck cancers serve as an ideal model to test combined laser
energy delivered via interstitial fiberoptics and chemotherapeutic agents activated by photo-thermal energy as an alternative, less invasive
treatment for cancer. A number of investigators have shown that anthracyclines and cisplatin are likely candidates for light or heat activation
in cancer cells. Maximum tolerated dose followed by photochemical and thermal activation via laser fiberoptics can improve treatment by
sensitizing tumor response. The higher intratumor drug levels compared to systemic drug administration along with laser activation should
also reduce systemic toxicity. In this presentation we review the concept of combining anti-cancer drugs and laser therapy and review the
clinical experience for this novel application.
Dr. Marcos Paiva's research focuses on the laser and chemotherapy for denaturation of cancer cells, including improving Nd:YAG laser thermal therapy for patients with recurrent head and neck cancer. With continuous funding from the National Cancer Institute (NIH) for the past 17 years, this translational study has progressed introducing a novel experimental treatment for cancer based on the concept of high doses of intratumor injections of chemotherapy (cisplatin) combined with localized infra-red hyperthermia.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals